Do you need fish oil supplements?
For most healthy adults, no. The reference intake for EPA and DHA is 250 mg a day[1], and a couple of portions of oily fish a week covers it. The largest trial of daily fish oil capsules found no reduction in heart attack, stroke or cardiovascular death[2]. Fish oil does lower triglycerides, but only at prescription doses[4]. A capsule is a reasonable patch if fish never reaches your table — not a health measure in itself.
On this page
What "omega-3" means on a label
Three different fatty acids share the name. ALA comes from plants — flaxseed, walnuts, rapeseed oil. EPA and DHA are the marine ones, found in oily fish, and they are what almost every piece of omega-3 research is actually about. The body can convert ALA into EPA and DHA, but it does so inefficiently, so a spoonful of flaxseed is not an interchangeable substitute for a portion of sardines.
This also explains the most common misreading of a supplement label. A capsule described as fish oil states the weight of the oil, not the weight of the two fatty acids inside it. The EPA and DHA content is printed separately, usually lower down, and it is often a fraction of the headline figure. The reference intake European authorities use for general cardiovascular health in adults is 250 mg of EPA and DHA combined per day[1], and the only way to know whether a product delivers it is to read that second line.
What the large trials found
The question that matters is not whether omega-3 does something in a test tube; it is whether swallowing it daily changes what happens to people. The largest test of that was a randomised trial of 25,871 adults who took either 1 g of EPA and DHA a day or a placebo for a median of 5.3 years. It found no reduction in the main outcome — heart attack, stroke or cardiovascular death — although heart attacks alone were slightly less frequent, 1.1 per cent against 1.5 per cent over the whole study[2].
A systematic review pooling the trial evidence reached the same place: long-chain omega-3 supplements make little or no difference to cardiovascular death, stroke or overall mortality[3]. That is a genuine finding, not an absence of one. The honest summary is that a general-purpose fish oil capsule, taken by a person with no particular condition, is unlikely to change their health in any way they will notice.
Where it does do something measurable
There is one clear exception, and it is a medical one. At doses far above what a supermarket capsule provides, EPA and DHA lower blood triglycerides: around 4 g a day reduces them by roughly 20 to 30 per cent in people whose levels are high[4]. That is a drug dose, delivered by prescription preparations and prescribed alongside the rest of someone's cardiovascular care, not something to arrange for yourself by multiplying up the capsules in a jar.
The distinction is worth holding on to, because it is the source of most of the confusion. "Omega-3 lowers triglycerides" is true at a clinical dose for a clinical problem. It does not follow that a daily capsule prevents heart disease in someone who does not have that problem — and the trials above tested exactly that and found it did not.
Food first, and what that looks like on an Arab table
The food-first argument here is the same one that applies to protein: whole food brings more than the single nutrient printed on the label, and it is usually cheaper. Oily fish is the practical route to EPA and DHA, and the cheapest versions are the best ones. Sardines, whether grilled fresh or out of a tin, are rich in both and cost very little. Mackerel is in the same class. Grey mullet is a staple of the Egyptian coast. Farmed white fish such as hamour, tilapia and sea bream are good protein but much leaner in omega-3, and canned light tuna sits well below sardines.
If fish genuinely does not appear in your week — a common situation inland, and in households where nobody likes cooking it — then a supplement is a reasonable patch for a gap, which is a different claim from a supplement being good for you. Vegetarians and anyone avoiding fish entirely can get EPA and DHA from algal oil, which is where the fish get theirs. For how fats fit into the rest of the day, the guide on splitting your calories between carbohydrate and fat covers the arithmetic, and how much protein you actually need makes the same food-before-powder case in more detail. If you are not sure whether fish is missing from your week or merely feels like it is, keeping a food record for a fortnight answers it faster than any argument; that is the kind of question an online nutrition coach is normally asked in the first session.
Dose, safety and the fine print
For a healthy adult, supplemental EPA and DHA at intakes up to 5 g a day have not raised safety concerns in European assessments[5], which comfortably covers any ordinary capsule. The side effects people actually meet are minor: fishy aftertaste and reflux, both reduced by taking the capsule with a meal or keeping it in the freezer.
Two cautions are real. Pooled trial data show that long-term marine omega-3 supplementation raises the risk of atrial fibrillation, and the risk rises with the dose[6] — which is one more reason not to self-prescribe the high intakes used for triglycerides. And anyone taking an anticoagulant, or preparing for surgery, should clear it with their doctor first.
The summary a reader can act on: aim for the daily reference intake through food, treat a capsule as a gap-filler rather than a health measure, read the EPA and DHA line rather than the one on the front of the box, and leave the gram-level doses to a prescription.
Sources
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on Dietary Reference Values for fats. EFSA Journal 2010;8(3):1461. ↩
- Manson JE, Cook NR, Lee I-M, et al. Marine n−3 fatty acids and prevention of cardiovascular disease and cancer (VITAL). New England Journal of Medicine 2019;380(1):23–32. ↩
- Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews 2020;3:CD003177. ↩
- Skulas-Ray AC, Wilson PWF, Harris WS, et al. Omega-3 fatty acids for the management of hypertriglyceridemia: a science advisory from the American Heart Association. Circulation 2019;140(12):e673–e691. ↩
- EFSA Panel on Dietetic Products, Nutrition and Allergies. Scientific Opinion on the tolerable upper intake level of EPA, DHA and DPA. EFSA Journal 2012;10(7):2815. ↩
- Gencer B, Djousse L, Al-Ramady OT, et al. Effect of long-term marine ω-3 fatty acids supplementation on the risk of atrial fibrillation in randomized controlled trials of cardiovascular outcomes: a systematic review and meta-analysis. Circulation 2021;144(25):1981–1990. ↩